debate: should consolidation and minimal residual disease testing be used? - yes
Published 9 years ago • 249 plays • Length 9:11Download video MP4
Download video MP3
Similar videos
-
9:07
debate: should consolidation and minimal residual disease testing be used? - no
-
21:09
minimal residual disease (mrd) in cll: is it clinically relevant?
-
21:18
myeloma debate: is mrd ready for prime time? - yes
-
5:05
should minimal residual disease (mrd) testing be routinely performed?
-
12:26
debate: mrd, ready for primetime? - yes
-
19:41
multiple myeloma: minimal residual disease
-
16:08
debate: is mrd the new primary goal for multiple myeloma treatment? - yes
-
3:07
minimal residual disease (mrd)
-
16:26
debate: is cr and mrd negativity still required in the era of novel agents? - no
-
10:19
myeloma debate: is mrd ready for prime time? - no
-
13:10
debate: is transplant a necessity or a choice for myeloma patients? - yes
-
4:20
an overview of minimal residual disease testing
-
22:56
measurable residual disease (mrd) in aml and all
-
4:44
minimal residual disease (mrd) | high impact topic (hit)
-
55:31
flow cytometry interpretation in b-all/lbl minimal residual disease testing
-
3:44
what is mrd, or minimal residual disease?
-
18:50
mrd detection, single cell rna seq., cell free dna, etc: does it impact treatment?
-
19:40
mrd evaluation in myeloma: a necessary clinical tool?
-
1:47
the importance of minimal residual disease in all